1. Home
  2. LVS vs ALC Comparison

LVS vs ALC Comparison

Compare LVS & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Las Vegas Sands Corp.

LVS

Las Vegas Sands Corp.

HOLD

Current Price

$61.82

Market Cap

45.5B

ML Signal

HOLD

Logo Alcon Inc.

ALC

Alcon Inc.

HOLD

Current Price

$80.70

Market Cap

39.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LVS
ALC
Founded
1988
1945
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Hotels/Resorts
Ophthalmic Goods
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.5B
39.0B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
LVS
ALC
Price
$61.82
$80.70
Analyst Decision
Buy
Buy
Analyst Count
13
12
Target Price
$67.08
$88.71
AVG Volume (30 Days)
4.7M
1.2M
Earning Date
01-28-2026
02-24-2026
Dividend Yield
1.63%
0.27%
EPS Growth
9.73
N/A
EPS
2.22
2.10
Revenue
$12,264,000,000.00
$10,185,000,000.00
Revenue This Year
$13.03
$5.76
Revenue Next Year
$5.64
$7.24
P/E Ratio
$27.73
$38.05
Revenue Growth
8.37
4.34
52 Week Low
$30.18
$71.55
52 Week High
$70.46
$99.20

Technical Indicators

Market Signals
Indicator
LVS
ALC
Relative Strength Index (RSI) 33.61 55.55
Support Level $64.80 $76.74
Resistance Level $65.62 $82.50
Average True Range (ATR) 1.12 1.17
MACD -0.66 0.02
Stochastic Oscillator 16.65 67.71

Price Performance

Historical Comparison
LVS
ALC

About LVS Las Vegas Sands Corp.

Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: